Story perspectives
Roche CEO Proposes 50% Drug Price Cut Strategy
7/25/2025
28 5
1 of 1
Story summary
- Roche CEO Thomas Schinecker believes slashing U.S. drug prices by 50% is possible by removing pharmacy benefit managers from the equation. The company is in talks with the U.S. government about direct-to-consumer sales to further cut costs. Amid these changes, Roche celebrated a 10% increase in U.S. pharmaceutical sales.
